Menu
Back to Journals » Biologics: Targets and Therapy » Volume 13
Original Research
Efficacy of adalimumab as second-line therapy in a pediatric cohort of Crohn’s disease patients who failed infliximab therapy: the Italian Society of Pediatric Gastroenterology, Hepatology, and Nutrition experience
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 11,057 | Dovepress* | 10,153+ | 1,880 | 12,033 | |
| PubMed Central* | 904 | 366 | 1,270 | ||
| Totals | 11,057 | 2,246 | 13,303 | ||
| *Since 3 January 2019 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 9 | 0 | 0 | 0 | 1 | 8 |
View citations on PubMed and Google Scholar